Biomedical Engineering Reference
In-Depth Information
7. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J
Suppl 2001; 34:50s-59s.
8. Caramori G, Adcock I. Pharmacology of airway inflammation in asthma and
COPD. Pulm Pharmacol Ther 2003; 16:247-277.
9. de Boer WI. Cytokines and therapy in COPD: a promising combination?
Chest 2002; 121(5 suppl):209S-218S.
10. Karin M, Shaulian E. AP-1: linking hydrogen peroxide and oxidative stress to
the control of cell proliferation and death. IUBMB Life 2001; 52:17-24.
11. Caramori G, Romagnoli M, Casolari P, Bellettato C, Casoni G, Boschetto P,
et al. Nuclear localisation of p65 in sputum macrophages but not in sputum
neutrophils during COPD exacerbations. Thorax 2003; 58:348-351.
12. Di Stefano A, Caramori G, Oates T, Capelli A, Lusuardi M, Gnemmi I, et al.
Increased expression of nuclear factor-kappaB in bronchial biopsies from
smokers and patients with COPD. Eur Respir J 2002; 20:556-563.
13. Rahman I. Oxidative stress and gene transcription in asthma and chronic
obstructive pulmonary disease: antioxidant therapeutic targets. Curr Drug
Targets Inflamm Allergy 2002; 1:291-315.
14. Shishodia S, Potdar P, Gairola CG, Aggarwal BB. Curcumin (diferuloyl-
methane) down-regulates cigarette smoke-induced NF-kappaB activation
through inhibition of IkappaBalpha kinase in human lung epithelial cells:
correlation with suppression of COX-2, MMP-9 and cyclin Dl. Carcino-
genesis 2003; 24:1269-1279.
15. Tomita K, Barnes PJ, Adcock IM. The effect of oxidative stress on histone acet-
ylation and IL-8 release. Biochem Biophys Res Commun 2003; 301:572-577.
16. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in
chronic inflammatory diseases. N Engl J Med 1997; 336:1066-1071.
17. Baldwin AS Jr. Series introduction: the transcription factor NF-kappaB and
human disease. J Clin Invest 2001; 107:3-6.
18. Ghosh S, Karin M. Missing pieces in the NF-
k
B puzzle. Cell 2002;
109(suppl):S81-S96.
19. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol
2002; 4:E131-E136.
20. Karin M, Chang L. AP-1-glucocorticoid receptor crosstalk taken to a higher
level. J Endocrinol 2001; 169:447-451.
21. Urnov FD, Wolffe AP. Chromatin remodeling and transcriptional activation:
the cast (in order of appearance). Oncogene 2001; 20:2991-3006.
22. Narlikar GJ, Fan HY, Kingston RE. Cooperation between complexes that
regulate chromatin structure and transcription. Cell 2002; 108:475-487.
23. Barnes PJ, Adcock IM. How do corticosteroids work in asthma? Ann Intern
Med 2003; 139(5 Pt 1):359-370.
24. Umland SP, Schleimer RP, Johnston SL. Review of the molecular and cellular
mechanisms of action of glucocorticoids for use in asthma. Pulm Pharmacol
Ther 2002; 15:35-50.
25. Adcock IM, Caramon G. Cross-talk between pro-inflammatory transcription
factors and glucocorticoids. Immunol Cell Biol 2001; 79:376-384.
26. Mittelstadt PR, Ashwell JD. Inhibition of AP-1 by the glucocorticoid-inducible
protein GILZ. J Biol Chem 2001; 276:29, 603-29, 610.
